Abstract
Background
Obesity has become a major global health problem and is dramatically increasing in the United States. The Center for Disease Control and Prevention estimates that over 42% of the United States population is obese, and projects that by 2030 all 50 states will have an obesity rate of 44% or greater, which could represent a $550 billion increase in obesity related national costs. 1 Obesity is associated with a number of pregnancy related complications for both mother and fetus. Risks for the mother include gestational diabetes, hypertension, preeclampsia, postpartum hemorrhage, cesarean delivery, and wound infection. 2 Risks for the fetus include prematurity, stillbirth, congenital anomalies, macrosomia with possible birth injury, and childhood obesity. It is estimated that one in two pregnancies in the United States are unintentional, and that one in five pregnancies will end in termination. A French national population based survey noted obese women are less likely to see a healthcare provider for contraception and more likely to report an unintended pregnancy. 3 Furthermore, they noted the odds of reporting an unintended pregnancy or an abortion were four times higher among women under 30 years if obese compared to those of normal weight. 3 The objective of this review was to evaluate and summarize existing literature addressing the implications of body mass index (BMI) on pregnancy termination.
Methods
Relevant articles were identified through PubMed, Cochrane Library, and MedlinePlus electronic databases searched and review of reference lists of the identified relevant published works. Six articles were identified from 1998-2012 and are included in this review.
Results
Dark et al. analyzed patient BMI and second trimester dilation and evacuation procedure outcomes on 163 women undergoing elective abortion at a single clinic. 4 Women with a BMI greater than or equal to 30 were compared to women of a lesser BMI. Procedure length for obese women was 20% longer compared to non-obese women. Providers rated the procedures 40% more difficult for obese women. Providers also noted that procedure length and difficulty, blood loss, and number of complications increased as BMI increased. The authors suggested that abortion providers should be aware of the trends identified, and consider special instruments and/or alterations in surgical technique for procedures on women with increased BMI.
Marchiano et al. analyzed 363 women between 5 and 24 weeks gestation confirmed by ultrasound to determine potential factors related to increased risk of blood loss. 5 Specific variables analyzed were maternal age, parity, smoking history, and body habitus. Patients were excluded for pregnancy demise, preterm premature rupture of membranes, and Potter's syndrome. While none of the factors significantly affected blood loss with dilation and curettage procedures in first trimester pregnancy terminations, simple and stepwise regression analyses suggested that BMI greater than or equal to 32.3 was the only variable significantly associated with increased blood loss in dilation and evacuation in second trimester pregnancy termination (p<0.05).
Cosby et al. surveyed 43 abortion providers in the same healthcare system in an urban-hospital based clinic and found no statistically significant difference in how challenging surgical abortions were in women of normal BMI, overweight BMI, and obese BMI. 6 However, it is likely the study was underpowered to demonstrate a difference as a review of the provider's responses noted that 15% of the surveyed providers claimed surgical abortions were "not challenging" in obese women compared women with normal BMI, while 85% of providers ranged their responses from "somewhat challenging" to "extremely challenging". Specific challenges noted for obese Obesity and pregnancy terminationwomen included visualizing the cervix, general anesthesia risks, and delays in care leading to increased gestational age.
Foster et al. performed a cross-sectional computer survey on 398 women presenting for second trimester elective abortion at a single urban hospital to evaluate the potential factors that cause a delay in abortion care. 7 The investigators divided the abortion process into three specific steps: 1) discovering one was pregnant, 2) calling a clinic for an abortion appointment, and 3) receiving an abortion procedure. Obesity was associated with a delay in discovering one was pregnant [hazard ratio (HR) 0.8, 95% CI 0.6-1.0]. Other factors that were associated with such a delay were drug and alcohol abuse, prior second-trimester abortion, unknown last menstrual period, denial, and fear of procedure.
Murphy et al. performed a retrospective review including 1044 women undergoing second-trimester termination of pregnancy with ultrasound guidance between 13 0/7 and 24 0/7 weeks gestational age to compare perioperative risks in obese and nonobese women (BMI < 30). 8 While the complication rate was similar between groups (5.5% nonobese and 7.6% obese), the operative times and anesthesia times were longer in obese patients (4.4 min and 5 min longer respectively, p<0.001 each). Additionally, history of one or more prior cesarean section was independently associated with major complication (p=0.001) and gestational age above 18 weeks showed a nonsignificant trend toward more complications (p=0.20). The authors suggested a potential for complications at advanced gestational age which was not statically confirmed. While this is the largest study evaluating obesity and second trimester termination of pregnancy identified for the review, the low complication rate decreased the power to detect a difference between groups.
Strafford et al. investigated outcomes of medical abortions in obese women compared to non-obese women. 9 The authors performed a retrospective chart review of 1,398 medical abortions from January 1, 2005 through December 31, 2007. All abortion regimens consisted of mifepristone 200 mg orally and misoprostol 800 micrograms vaginally or buccally within 24 hours. Women were excluded due to nonviable pregnancy, incomplete abortion, missing data, or an age younger than 18 years. Of the 1,398 charts reviewed, 1,202 women were eligible for study inclusion of which 861 women had a BMI of less than 30, and 341 women had a BMI of greater than or equal to 30. The outcome following medical abortion was similar among both groups of women. Specifically, there was no significant difference between obese and non-obese women in terms of need for uterine aspiration post initial abortion, completed abortion within two weeks of medication administration, number of additional clinic visits, additional doses of misoprostol, and loss to follow up. Additional comparisons were analyzed in stratified BMI categories with no statistically significant comparisons suggesting the rates of the studied outcomes are similar across all BMI categories.
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Discussion
Pregnancy termination on obese women may impart additional technical challenges. While experienced providers are able to complete procedures in obese women without statistically significant differences in procedure or patient outcomes compared to normal weight women for first trimester gestations, pharmacological abortion may be a more practical option in some very obese women. From the limited evidence available for review, providers should be aware that obesity was noted to have significant effects on later gestation (second trimester) abortion outcomes.
Available information regarding the risks of procedures should be presented to patients during counseling. It is imperative to note data regarding the effects of obesity with pregnancy termination is limited by the small number of studies, and methodologies. Due to the increasing obesity epidemic within this country and worldwide, further research should be conducted including BMI stratification with analysis between non-obese, obese, and morbidly obese women.
